Filter
1305
Filtered Results: 1305
Text search:
molecular
testing
Featured
Recommendations
173
New Publications
267
Language
Document type
No document type
608
Guidelines
279
Studies & Reports
236
Manuals
71
Strategic & Response Plan
58
Fact sheets
27
Training Material
14
Situation Updates
7
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
81
Global
44
Western and Central Europe
44
Latin America and the Carribbean
34
Kenya
28
Africa
24
Eastern Europe
24
South Africa
23
Tanzania
22
Ethiopia
20
Brazil
18
Germany
16
Nigeria
14
West and Central Africa
13
East and Southern Africa
13
Sierra Leone
12
Malawi
12
Rwanda
11
South–East Asia Region
11
Russia
11
Philippines
10
Uganda
10
Colombia
9
Peru
9
Zimbabwe
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
USA
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Senegal
4
Burkina Faso
4
Middle East and North Africa
4
Ecuador
4
Pakistan
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
North America
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
405
Clinical Guidelines
182
Pharmacy & Technologies
55
Public Health
50
Key Resources
27
Women & Child Health
19
Capacity Building
5
Toolboxes
TB
267
COVID-19
173
AMR
107
NTDs
88
HIV
86
Rapid Response
66
Ebola & Marburg
37
Mental Health
34
Planetary Health
27
Pharmacy
27
Zika
20
Refugee
16
NCDs
15
Polio
12
Specific Hazards
11
Health Financing Toolbox
8
Caregiver
6
Cholera
5
Malaria
5
Conflict
5
Natural Hazards
4
Disability
4
Global Health Education
2
Social Ethics
1
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
To implement the set of recommendations on the marketing of foods and non-alcoholic beverages to children
With the growing obesity crisis among children, WHO and other public health advocates and consumer groups have called for restrictions on advertising of ‘unhealthy foods’ high in salt, ...
With the growing obesity crisis among children, WHO and other public health advocates and consumer groups have called for restrictions on advertising of ‘unhealthy foods’ high in salt, ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Accessed: 19.10.2019
des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Recommendations for Diagnosis and Treatment of Nontuberculous Mycobacterioses of the German Central Committee against Tuberculosis and the German Respirator...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Se estima que unos 10 millones de personas contrajeron tuberculosis (TB) en el 2019 y que a unos 3 millones de ellas no se les diagnosticó ni se les notificó la enfermedad. Con el propósito de poner fin a la epidemia mundial de la tuberculosis para el 2030, sigue siendo necesario ampliar la capac...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Every year, nearly 250 million people move across borders temporarily or permanently for a job opportunity, studying, to flee a crisis back home, or for other reasons. Another 750 million move for similar reasons within the borders of their countries. With the understanding that human mobility affec...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
January 2020 to December 2021
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T...
